splenotritin and Osteosarcoma
splenotritin has been researched along with Osteosarcoma in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bruland, ØS; Onda, M; Pastan, I | 1 |
Ek, O; Myers, DE; Uckun, FM; Waurzyniak, B | 1 |
Aurlien, E; Kvinnsland, Y; Stokke, T | 1 |
Other Studies
3 other study(ies) available for splenotritin and Osteosarcoma
Article | Year |
---|---|
TP-3 immunotoxins improve antitumor activity in mice with osteosarcoma.
Topics: Animals; Bone Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Immunotoxins; Mice; Mice, SCID; Osteosarcoma; Peptide Fragments; Thymopoietins; Treatment Outcome; Xenograft Model Antitumor Assays | 2005 |
Antitumor activity of TP3(anti-p80)-pokeweed antiviral protein immunotoxin in hamster cheek pouch and severe combined immunodeficient mouse xenograft models of human osteosarcoma.
Topics: Animals; Cheek; Cricetinae; Drug Screening Assays, Antitumor; Female; Humans; Immunotoxins; Mesocricetus; Mice; Mice, SCID; Mouth Mucosa; N-Glycosyl Hydrolases; Osteosarcoma; Peptide Fragments; Plant Proteins; Ribosome Inactivating Proteins, Type 1; Thymopoietins; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei.
Topics: Alpha Particles; Antigens, CD20; Antigens, Neoplasm; Bone Neoplasms; Burkitt Lymphoma; Cell Nucleus; Cell Size; Cell Survival; Energy Transfer; Flow Cytometry; Humans; Models, Biological; Osteosarcoma; Peptide Fragments; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Thymopoietins; Tumor Cells, Cultured | 2001 |